Poster Highlighting Qualigen Therapeutics’ Pan-RAS Inhibitor Platform Presented at American Society of Clinical Oncology (ASCO) 2023 Annual Meeting Preclinical Data Show Potential to Overcome Resistance to Key KRAS-G12C Therapeutic Compounds CARLSBAD, Calif., June 05, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a...

Quanta Therapeutics Appoints Leonardo Faoro, MD, as Chief Medical Officer – US board-certified medical oncologist with extensive global clinical and regulatory experience advancing oncology medicines from early development stages through to approval – – Quanta is...